Romilkimab
Romilkimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Romilkimab is under investigation in clinical trial NCT02345070 (Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis).
| Trade Name | Romilkimab |
| Generic | Romilkimab |
| Romilkimab Other Names | Hutbti3_2_1, Romilkimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Romilkimab
